Technology
Materialise N.V.(MTLS)
Live Price
Offline$6.71
+1.51% today
1Y Change
+22.89%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $280.00M
- Revenue Growth
- -3.6%
- EPS Growth
- -43.5%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Materialise N.V. (MTLS) is a Technology stock with a market cap of $280.00M and listed on NASDAQ. The stock last traded around $6.71 and up 22.9% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of -3.6%, EPS growth of -43.5%, a dividend yield of 0.0%. What stands out right now is revenue -3.6%, EPS -43.5%, free cash flow +79.9% with operating margin 2.9% and ROIC 2.4%. Valuation already assumes a fairly strong business story at P/E 35.5 and price/sales 1.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MTLS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-3.6% vs +11.9% peer median
Operating Margin
Below sector median
+2.9% vs +22.0% peer median
P/E
Above sector median
35.5 vs 18.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 29, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -3.6% and EPS is at -43.5%, with operating margin around 2.9%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +3.2% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 29, 2026 | โ | +5.0% | +7.5% | +23.9% |
2026 Feb 19, 2026 | +70.3% | -8.1% | -9.8% | -15.4% |
2025 Oct 28, 2025 | +300.0% | -3.9% | +12.1% | +6.7% |
Benchmark Edge
MTLS vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MTLS
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MTLS Max Drawdown
-27.27%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MTLS and SPY.
Company Overview
Materialise N.V.
NASDAQ Global Select
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
- Leadership
- Brigitte de Vet-Veithen
- IPO Date
- Jun 25, 2014
- Employees
- 488
- Street Address
- Technologielaan 15
- Mailing
- Leuven, 3001
- Region
- Leuven, BE
- Reporting Currency
- USD
- Investor Line
- 32 1 639 66 11
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 35.5
- EV/EBITDA
- 5.7
- Price/Sales
- 1.0
- Price/Book
- 1.1
Growth
- Revenue
- -3.6%
- EPS
- -43.5%
- Free Cash Flow
- +79.9%
Profitability
- Gross Margin
- 57.1%
- Operating Margin
- 2.9%
- Net Margin
- 2.9%
- ROE
- 3.2%
- ROIC
- 2.4%
Balance Sheet
- Debt/Equity
- 0.26
- Current Ratio
- 2.43
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.